Cubicin Related Clinical Trials
Phase 4 Efficacy and Safety Study of CubicinŽ With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE) [Terminated]
Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty [Terminated]
Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease [Completed]
Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin [Active, not recruiting]
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD) [Completed]
Cubicin(R) for Complicated Post-Surgical Wound Infections [Terminated]
Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection [Not yet recruiting]
Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery [Completed]
Comparative Evaluation of the Safety & Efficacy of Daptomycin Versus SOC in 2 - 17 yr Olds With Staphylococcus Aureus Bacteremia [Recruiting]
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci [Completed]
Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia [Recruiting]
Daptomycin in Pediatric Patients With Bacterial Meningitis [Suspended]
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer [Completed]
Daptomycin Versus Placebo in Patients With Neutropenia and Fever [Terminated]
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA [Completed]
Catheter Related - Gram Positive Bloodstream Infections [Completed]
Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment [Terminated]
Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting [Terminated]
Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment [Terminated]
Cerebrospinal Fluid Pharmacokinetics of Daptomycin [Terminated]
The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock [Recruiting]
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections [Completed]
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections [Completed]
An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants [Completed]
Study to Evaluate Daptomycin Given During Dialysis and After Dialysis [Completed]
Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus [Completed]
Study Comparing CUBICINŽ (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas [Completed]
Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections [Completed]
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections [Terminated]
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections [Terminated]
Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China [Completed]
Population Pharmacokinetic (PK) Study of Multiple Doses of CubicinŽ (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure [Recruiting]
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics [Completed]
Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia [Terminated]
Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use [Withdrawn]
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice [Completed]
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis [Terminated]
Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury [Recruiting]
Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection [Recruiting]
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections [Terminated]
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections [Completed]
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy [Withdrawn]
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus [Completed]
China Registration Study in Patients With Skin Infections [Completed]
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis. [Terminated]
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections [Completed]
Safety Study to Evaluate Daptomycin in Non-Infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis [Completed]
Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia [Recruiting]
Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis [Completed]
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens [Terminated]
A Pilot Study of Daptomycin for Antimicrobial Prophylaxis [Terminated]
Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration [Recruiting]
Concentration of Antimicrobials in Catheter-lock Solutions [Active, not recruiting]
Daptomycin Study - Collection of Pharmacokinetic Samples in Patients With Renal Failure [Completed]
The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin [Completed]
Clinical Evaluation of Daptomycin Bone Penetration [Recruiting]
Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections [Completed]
Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs) [Terminated]
Study of Single Dose Daptomycin in Pediatric Patients With Gram-Positive Infection for Which They Are Receiving Standard Antibiotics [Completed]
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections [Completed]
A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) [Completed]
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria [Completed]
A Phase 3 Telavancin Staphylococcus Aureus Bacteremia Trial [Recruiting]
Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections [Active, not recruiting]
Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study [Recruiting]
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus [Completed]
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options [Recruiting]
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis [Recruiting]
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients [Terminated]
Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2) [Recruiting]
Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia [Completed]
Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections [Not yet recruiting]
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection [Recruiting]
Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection [Not yet recruiting]
Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection [Terminated]
Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation [Withdrawn]
Reduction of Nosocomial Vancomycin -Resistant Enterococci (VRE) Colonization and Infection by Active Surveillance and Intervention of Infection Control [Completed]
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil [Not yet recruiting]
|
